Research.Patient.info
Advanced Lymphoid Leukemia research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1
A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19
This study is checking on the long-term safety and effects of a treatment called UCART19 for people with advanced lymphoid leukaemia. It follows up with patients who have already had this treatment to see how they are doing over time.
United States · France · Japan - authorisedTherapeutic confirmatory (Phase III)
Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)
This study is checking on the long-term health of people, including children, who have previously received a special treatment called UCART19 for advanced leukaemia. Researchers want to understand if there are any side effects over time and how patients are doing generally after treatment.
France